Takaaki Kigoshi

Takaaki Kigoshi

Auto-generated profile, based on publicly available information

Takaaki Kigoshi

Department of Mucosal Immunology, The University of Tokyo Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
Yosuke KurashimaYosuke Kurashima
Yosuke Kurashima
TKTakaaki Kigoshi
Takaaki Kigoshi
SMSayuri Murasaki
Sayuri Murasaki
FAFujimi Arai
Fujimi Arai
KSKaoru Shimada
Kaoru Shimada
HKHiroshi Kiyono
Hiroshi Kiyono
Increases in adhesive and invasive commensal bacteria, such as Escherichia coli, and subsequent disruption of the epithelial barrier is implicated in the pathogenesis of inflammatory bowel disease (IBD). However, the protective systems against such barrier disruption are not fully understood. Here, we show that secretion of luminal glycoprotein 2 (GP2) from pancreatic acinar cells is induced in a TNF–dependent manner in mice with chemically induced colitis. Fecal GP2 concentration is also increased in Crohn’s diease patients. Furthermore, pancreas-specific GP2-deficient colitis mice have more severe intestinal inflammation and a larger mucosal E. coli population than do intact mice, indicating that digestive-tract GP2 binds commensal E. coli, preventing epithelial attachment and penetration. Thus, the pancreas–intestinal barrier axis and pancreatic GP2 are important as a first line of defense against adhesive and invasive commensal bacteria during intestinal inflammation.